DNM1L and lung adenocarcinoma: Our investigation helped to decipher the clinical significance of DRP1 in patients with early‐stage lung adenocarcinoma, showing that the increase in DRP1 expression and activation is correlated with enhanced proliferation and disease extent and is independently associated with early postoperative recurrence.